Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

Abstract

This is the largest genomic characterization of clinically annotated rhabdomyosarcoma tumors to date and provides prognostic genetic features that refine risk stratification and will be incorporated into prospective trials.